• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

声门鳞状细胞癌伴皮肤转移的治疗

Management of a glottic squamous cell carcinoma with cutaneous metastasis.

作者信息

Alkan Ali, Kayış Deniz, Çelik Serkan Yaşar, Uylaş Selçuk, Demir Pektaş Suzan, Oral Tapan Özge, Gökdoğan Ozan, Türkkan Görkem, Genç Sebahat, Tanrıverdi Özgür

机构信息

Medical Oncology, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.

Internal Medicine, Muğla Sıtkı Koçman University School of Medicine, Muğla, Turkey.

出版信息

J Oncol Pharm Pract. 2020 Sep;26(6):1495-1498. doi: 10.1177/1078155219900782. Epub 2020 Feb 6.

DOI:10.1177/1078155219900782
PMID:32028840
Abstract

INTRODUCTION

Oral cavity malignancies constitute 30% of head and neck cancers. The most common distant metastatic sites of glottic carcinoma are usually lung, liver and bone. Although the cutaneous metastasis of head and cancers have been reported with an incidence of 0.7-2.4%, skin metastasis of glottic carcinoma is extremely rare.

CASE REPORT

A 69-year-old male patient was admitted to the emergency department with hemoptysis, dyspnea, weakness in lower extremities and difficulty in swallowing. There were subcutaneous lesions with a diameter of 2-5 cm in the scalp, posterior chest wall, nose and abdomen. In addition, there was an ulcerating, painful mass on the right lateral part of the tongue. The biopsy of lesions on tongue and skin revealed a glottic squamous cell carcinoma with cutaneous metastasis. The patient was treated with cisplatin 50 mg/m on day 1, cetuximab 500 mg/m on day 1 and 5-fluorouracil 1000 mg/m daily on days 1 and 2, repeated every two weeks. After the first cycle of chemotherapy, the lesions on the skin regressed and dysphagia improved.

DISCUSSION

There are limited data about the incidence, diagnostic measures and treatment modalities of glottic cancer with cutaneous metastasis. Our case could provide an important experience to literature by its atypical presentation and treatment-sensitive nature.

摘要

引言

口腔恶性肿瘤占头颈癌的30%。声门癌最常见的远处转移部位通常是肺、肝和骨。尽管头颈部癌症的皮肤转移已有报道,发生率为0.7%-2.4%,但声门癌的皮肤转移极为罕见。

病例报告

一名69岁男性患者因咯血、呼吸困难、下肢无力和吞咽困难入住急诊科。头皮、后胸壁、鼻子和腹部有直径2-5厘米的皮下病变。此外,舌右侧有一个溃疡、疼痛的肿块。舌部和皮肤病变的活检显示为伴有皮肤转移的声门鳞状细胞癌。患者接受了第1天顺铂50mg/m、第1天西妥昔单抗500mg/m以及第1天和第2天每日5-氟尿嘧啶1000mg/m的治疗,每两周重复一次。第一个化疗周期后,皮肤病变消退,吞咽困难改善。

讨论

关于伴有皮肤转移的声门癌的发病率、诊断方法和治疗方式的数据有限。我们的病例因其非典型表现和对治疗敏感的性质可为文献提供重要经验。

相似文献

1
Management of a glottic squamous cell carcinoma with cutaneous metastasis.声门鳞状细胞癌伴皮肤转移的治疗
J Oncol Pharm Pract. 2020 Sep;26(6):1495-1498. doi: 10.1177/1078155219900782. Epub 2020 Feb 6.
2
Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.丙戊酸联合顺铂和西妥昔单抗治疗复发和/或转移性头颈部鳞状细胞癌的II期临床研究-V-CHANCE试验
BMC Cancer. 2016 Nov 25;16(1):918. doi: 10.1186/s12885-016-2957-y.
3
Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108).西妥昔单抗联合氟尿嘧啶和顺铂或多西他赛治疗复发性和/或转移性头颈部鳞状细胞癌患者(CeFCiD):一项开放标签、二期随机试验(AIO/IAG-KHT 试验 1108)。
Eur J Cancer. 2019 Nov;122:53-60. doi: 10.1016/j.ejca.2019.08.018. Epub 2019 Oct 13.
4
Clinical outcomes of platinum-based chemotherapy plus cetuximab for recurrent or metastatic squamous cell carcinoma of the head and neck: comparison between platinum-sensitive and platinum-resistant patients.铂类化疗联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌的临床疗效:铂敏感与铂耐药患者的比较
Acta Otolaryngol. 2019 Feb;139(2):201-205. doi: 10.1080/00016489.2018.1551623. Epub 2019 Feb 22.
5
Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.多西他赛、顺铂和氟尿嘧啶用于不可切除的复发性或转移性头颈部鳞状细胞癌患者。
Auris Nasus Larynx. 2015 Oct;42(5):396-400. doi: 10.1016/j.anl.2015.02.009. Epub 2015 Feb 23.
6
Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.顺铂-氟尿嘧啶单纯化疗用于T1-T3N0声门鳞状细胞癌完全临床缓解者:五年结果
J Clin Oncol. 1996 Aug;14(8):2331-6. doi: 10.1200/JCO.1996.14.8.2331.
7
Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer.两例西妥昔单抗、紫杉醇和顺铂联合治疗晚期头颈癌的病例
J Oncol Pharm Pract. 2018 Oct;24(7):553-554. doi: 10.1177/1078155217722406. Epub 2017 Aug 1.
8
Phase II trial of combination treatment with paclitaxel, carboplatin and cetuximab (PCE) as first-line treatment in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CSPOR-HN02).紫杉醇、卡铂和西妥昔单抗联合治疗作为复发性和/或转移性头颈部鳞状细胞癌(CSPOR-HN02)一线治疗的 II 期临床试验。
Ann Oncol. 2018 Apr 1;29(4):1004-1009. doi: 10.1093/annonc/mdy040.
9
Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.初诊转移性头颈部鳞状细胞癌患者接受局部区域放疗的影响。
Oral Oncol. 2019 Jun;93:46-51. doi: 10.1016/j.oraloncology.2019.04.005. Epub 2019 Apr 15.
10
Patritumab or placebo, with cetuximab plus platinum therapy in recurrent or metastatic squamous cell carcinoma of the head and neck: A randomised phase II study.培妥珠单抗或安慰剂联合西妥昔单抗和铂类药物治疗复发或转移性头颈部鳞状细胞癌的随机 II 期研究。
Eur J Cancer. 2019 Dec;123:36-47. doi: 10.1016/j.ejca.2019.08.017. Epub 2019 Oct 21.